◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states ◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states
Home / Formulary / Ipamorelin
Back to formulary
Ipamorelin — LORIUM lyophilised vial LORIUM · 10 mg LYOPHILISED VIAL
Third-party tested · COA included with every lot
Growth ● In stockPrescription required

Ipamorelin

GH secretagogue · IPAMORELIN

Ipamorelin is a premium synthetic pentapeptide and a highly selective growth hormone secretagogue (GHS) engineered to target the GHS-R1a receptor with absolute precision. By exclusively stimulating pituitary growth hormone release without disrupting other endocrine pathways, this advanced protocol mimics the body's natural pulsatile cycles to maximize tissue repair and systemic rejuvenation.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Selective GH Stimulation

Amplifies natural growth hormone production with zero impact on baseline cortisol or ACTH.

Physiological Pulse Patterns

Smoothly mimics the body's natural endogenous cycles for maximum cellular safety.

Ultra-Selective Action

Stimulates GH release without affecting cortisol or prolactin.

Extended Half-Life

Features a ~2-hour half-life, outperforming traditional GHRPs.

Advanced Tissue Repair

Leverages active GH-mediated pathways to accelerate injury healing and structural recovery.

Body Composition Refinement

Supports targeted fat metabolism while actively preserving and building lean mass.

Sleep Architecture Support

Indirectly enhances deep, restorative slow-wave sleep cycles via natural GH release.

Specifications

ClassGH secretagogue
CAS number170851-70-4
Molar mass711.9 g/mol
Available sizes10 mg
AdministrationPremium daily subcutaneous protocol.
CategoryGrowth
View a sample certificate of analysis →

Clinical references

  1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561.
  2. Gobburu JV, Agersø H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide. Pharm Res. 1999;16(9):1412-1416.
  3. Andersen NB, Malmlöf K, Johansen PB, et al. The growth hormone secretagogue ipamorelin and gastrointestinal motility. Neurogastroenterol Motil. 1999.
Related

More in Growth

View all →